Pinnacle Bank grew its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 3.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,715 shares of the healthcare conglomerate’s stock after purchasing an additional 55 shares during the period. Pinnacle Bank’s holdings in UnitedHealth Group were worth $506,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds also recently added to or reduced their stakes in the company. Ashfield Capital Partners LLC grew its holdings in shares of UnitedHealth Group by 10.1% during the first quarter. Ashfield Capital Partners LLC now owns 69,551 shares of the healthcare conglomerate’s stock valued at $17,345,000 after buying an additional 6,395 shares during the last quarter. Global Trust Asset Management LLC boosted its stake in UnitedHealth Group by 47.9% during the 4th quarter. Global Trust Asset Management LLC now owns 2,160 shares of the healthcare conglomerate’s stock valued at $635,000 after purchasing an additional 700 shares during the last quarter. Bluefin Trading LLC increased its holdings in UnitedHealth Group by 503.4% during the 4th quarter. Bluefin Trading LLC now owns 36,464 shares of the healthcare conglomerate’s stock worth $10,720,000 after purchasing an additional 30,421 shares in the last quarter. Wishbone Management LP purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth approximately $51,447,000. Finally, MU Investments Co. Ltd. lifted its holdings in shares of UnitedHealth Group by 4.1% in the first quarter. MU Investments Co. Ltd. now owns 16,870 shares of the healthcare conglomerate’s stock valued at $4,239,000 after purchasing an additional 670 shares in the last quarter. 86.59% of the stock is currently owned by institutional investors.
In related news, Director Stephen J. Hemsley sold 45,637 shares of UnitedHealth Group stock in a transaction on Monday, May 11th. The stock was sold at an average price of $289.11, for a total transaction of $13,194,113.07. Following the completion of the sale, the director now owns 1,013,122 shares of the company’s stock, valued at $292,903,701.42. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.80% of the stock is owned by company insiders.
NYSE UNH traded down $2.69 during trading hours on Tuesday, hitting $300.13. The company had a trading volume of 822,441 shares, compared to its average volume of 3,487,117. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.75 and a current ratio of 0.75. The firm has a market capitalization of $284.69 billion, a price-to-earnings ratio of 21.08, a PEG ratio of 1.47 and a beta of 0.72. UnitedHealth Group Inc has a 52 week low of $187.72 and a 52 week high of $315.84. The firm has a 50 day simple moving average of $295.78 and a 200 day simple moving average of $282.68.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Wednesday, April 15th. The healthcare conglomerate reported $3.72 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.63 by $0.09. UnitedHealth Group had a net margin of 5.59% and a return on equity of 24.86%. The firm had revenue of $64.40 billion for the quarter, compared to the consensus estimate of $64.25 billion. During the same period in the prior year, the firm posted $3.73 earnings per share. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. On average, research analysts forecast that UnitedHealth Group Inc will post 16.24 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Monday, June 22nd were paid a $1.25 dividend. The ex-dividend date of this dividend was Friday, June 19th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.08. This represents a $5.00 annualized dividend and a yield of 1.67%. UnitedHealth Group’s dividend payout ratio is currently 33.09%.
Several equities analysts have weighed in on UNH shares. Stephens raised their price objective on UnitedHealth Group from $310.00 to $325.00 and gave the company an “overweight” rating in a research note on Tuesday, June 2nd. Deutsche Bank dropped their target price on shares of UnitedHealth Group from $308.00 to $293.00 and set a “buy” rating on the stock in a research report on Thursday, April 16th. ValuEngine lowered UnitedHealth Group from a “hold” rating to a “sell” rating in a report on Thursday, July 2nd. Morgan Stanley lifted their price target on UnitedHealth Group from $289.00 to $371.00 and gave the stock an “overweight” rating in a report on Thursday, April 30th. Finally, Credit Suisse Group restated a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday, May 27th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and twenty-two have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $324.67.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: Net Asset Value
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.